Good Therapeutics

Developer of protein-based drugs for cancer

placeSeattle, Washington, United States calendar_todayFounded 2016 groups23 employees language goodtherapeutics.com

Registered entities

Investor mix

6 investors on record; lead investors include Roche, RiverVest Venture Partners, Digitalis Ventures, 3x5 Partners.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%
Coming soon